Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J GREENBLATT

Showing results (821-830 of 874) with videos related to

Pageof 88
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 16, 2002
Microsomal protein concentration modifies the apparent inhibitory potency of CYP3A inhibitorsThanh Huu Tran, Lisa L Von Moltke, Karthik Venkatakrishnan, et al.
Journal of Clinical Psychopharmacology|August 5, 1998
Appetite suppressant drugs as inhibitors of human cytochromes P450: in vitro inhibition of P450-2D6 by D- and L-fenfluramine, but not phentermineL L von Moltke, D J Greenblatt, D A Ciraulo, et al.
Pharmacogenetics|July 31, 2004
Identification of common polymorphisms in the promoter of the UGT1A9 gene: evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liverHugo Girard, Michael H Court, Olivier Bernard, et al.
Biopharmaceutics & Drug Disposition|September 22, 2011
Pharmacokinetic profile of SKP-1041, a modified release formulation of zaleplonDavid J Greenblatt, Jerold S Harmatz, James K Walsh, et al.
Journal of Clinical Pharmacology|January 25, 2006
Pharmacokinetics and pharmacodynamics of multiple sublingual buprenorphine tablets in dose-escalation trialsDomenic A Ciraulo, Robert J Hitzemann, Eugene Somoza, et al.
Blood|June 1, 1995
Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantationC E Dunbar, M Cottler-Fox, J A O'Shaughnessy, et al.
Hepatology (Baltimore, Md.)|June 30, 2005
UGT1A1 polymorphisms are important determinants of dietary carcinogen detoxification in the liverHugo Girard, Jean Thibaudeau, Michael H Court, et al.
Journal of Clinical Pharmacology|February 28, 2001
Inhibition of human cytochrome P450 isoforms by nonnucleoside reverse transcriptase inhibitorsL L von Moltke, D J Greenblatt, B W Granda, et al.
Journal of Clinical Psychopharmacology|January 17, 2007
Comparison of duloxetine, escitalopram, and sertraline effects on cytochrome P450 2D6 function in healthy volunteersSheldon H Preskorn, David J Greenblatt, David Flockhart, et al.
Antimicrobial Agents and Chemotherapy|May 14, 2014
Isoniazid mediates the CYP2B6*6 genotype-dependent interaction between efavirenz and antituberculosis drug therapy through mechanism-based inactivation of CYP2A6Michael H Court, Fawziah E Almutairi, David J Greenblatt, et al.
Pageof 88

Showing results (821-830 of 874) with videos related to

Sort By:
Pageof 88
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 16, 2002
Microsomal protein concentration modifies the apparent inhibitory potency of CYP3A inhibitorsThanh Huu Tran, Lisa L Von Moltke, Karthik Venkatakrishnan, et al.
Journal of Clinical Psychopharmacology|August 5, 1998
Appetite suppressant drugs as inhibitors of human cytochromes P450: in vitro inhibition of P450-2D6 by D- and L-fenfluramine, but not phentermineL L von Moltke, D J Greenblatt, D A Ciraulo, et al.
Pharmacogenetics|July 31, 2004
Identification of common polymorphisms in the promoter of the UGT1A9 gene: evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liverHugo Girard, Michael H Court, Olivier Bernard, et al.
Biopharmaceutics & Drug Disposition|September 22, 2011
Pharmacokinetic profile of SKP-1041, a modified release formulation of zaleplonDavid J Greenblatt, Jerold S Harmatz, James K Walsh, et al.
Journal of Clinical Pharmacology|January 25, 2006
Pharmacokinetics and pharmacodynamics of multiple sublingual buprenorphine tablets in dose-escalation trialsDomenic A Ciraulo, Robert J Hitzemann, Eugene Somoza, et al.
Blood|June 1, 1995
Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantationC E Dunbar, M Cottler-Fox, J A O'Shaughnessy, et al.
Hepatology (Baltimore, Md.)|June 30, 2005
UGT1A1 polymorphisms are important determinants of dietary carcinogen detoxification in the liverHugo Girard, Jean Thibaudeau, Michael H Court, et al.
Journal of Clinical Pharmacology|February 28, 2001
Inhibition of human cytochrome P450 isoforms by nonnucleoside reverse transcriptase inhibitorsL L von Moltke, D J Greenblatt, B W Granda, et al.
Journal of Clinical Psychopharmacology|January 17, 2007
Comparison of duloxetine, escitalopram, and sertraline effects on cytochrome P450 2D6 function in healthy volunteersSheldon H Preskorn, David J Greenblatt, David Flockhart, et al.
Antimicrobial Agents and Chemotherapy|May 14, 2014
Isoniazid mediates the CYP2B6*6 genotype-dependent interaction between efavirenz and antituberculosis drug therapy through mechanism-based inactivation of CYP2A6Michael H Court, Fawziah E Almutairi, David J Greenblatt, et al.
Pageof 88